103 related articles for article (PubMed ID: 27247849)
1. Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects.
Barratt DT; Klepstad P; Dale O; Kaasa S; Somogyi AA
Pharmacogenomics J; 2024 Jun; 24(3):18. PubMed ID: 38824169
[TBL] [Abstract][Full Text] [Related]
2. The effect of opioids on the cognitive function of older adults: results from the Personality and Total Health through life study.
Neelamegam M; Zgibor J; Chen H; O'rourke K; Bakour C; Rajaram L; Anstey KJ
Age Ageing; 2021 Sep; 50(5):1699-1708. PubMed ID: 33755047
[TBL] [Abstract][Full Text] [Related]
3. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
[TBL] [Abstract][Full Text] [Related]
4. Home-based specialized palliative care in patients with advanced cancer: A systematic review.
Nordly M; Vadstrup ES; Sjøgren P; Kurita GP
Palliat Support Care; 2016 Dec; 14(6):713-724. PubMed ID: 27407075
[TBL] [Abstract][Full Text] [Related]
5. Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients.
Csajka C; Crettol S; Guidi M; Eap CB
Clin Pharmacokinet; 2016 Dec; 55(12):1521-1533. PubMed ID: 27286724
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic landscape of pain management variants among Mediterranean populations.
Jmel H; Boukhalfa W; Gouiza I; Seghaier RO; Dallali H; Kefi R
Front Pharmacol; 2024; 15():1380613. PubMed ID: 38813106
[TBL] [Abstract][Full Text] [Related]
7. Translational Genomic Research: The Association between Genetic Profiles and Cognitive Functioning or Cardiac Function Among Breast Cancer Survivors Completing Chemotherapy.
Park JY; Lengacher CA; Reich RR; Park HY; Whiting J; Nguyen AT; Rodríguez C; Meng H; Tinsley S; Chauca K; Gordillo-Casero L; Wittenberg T; Joshi A; Lin K; Ismail-Khan R; Kiluk JV; Kip KE
Biol Res Nurs; 2022 Oct; 24(4):433-447. PubMed ID: 35499926
[No Abstract] [Full Text] [Related]
8. Relationship of Postoperative Pain and PONV after Minimally Invasive Surgery with the Serotonin Concentrations and Receptors' Gene Polymorphisms.
Ignaszak-Kaus N; Duleba AJ; Mrozikiewicz A; Kurzawińska G; Różycka A; Hauke J; Gaca M; Pawelczyk L; Jagodziński PP; Jędrzejczak P
J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575611
[TBL] [Abstract][Full Text] [Related]
9. Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review.
Lucenteforte E; Vannacci A; Crescioli G; Lombardi N; Vagnoli L; Giunti L; Cetica V; Coniglio ML; Pugi A; Bonaiuti R; Aricò M; Giglio S; Messeri A; Barale R; Giovannelli L; Mugelli A; Maggini V
BMC Cancer; 2019 Jan; 19(1):113. PubMed ID: 30704436
[TBL] [Abstract][Full Text] [Related]
10. Development of an AmpliSeq
Kringel D; Kaunisto MA; Lippmann C; Kalso E; Lötsch J
Front Pharmacol; 2018; 9():1008. PubMed ID: 30283335
[No Abstract] [Full Text] [Related]
11. Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR[BC]).
Park JY; Lengacher CA; Reich RR; Alinat CB; Ramesar S; Le A; Paterson CL; Pleasant ML; Park HY; Kiluk J; Han H; Ismail-Khan R; Kip KE
Transl Behav Med; 2019 Jul; 9(4):693-702. PubMed ID: 30137607
[TBL] [Abstract][Full Text] [Related]
12. OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.
Hajj A; Halepian L; Osta NE; Chahine G; Kattan J; Rabbaa Khabbaz L
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346387
[TBL] [Abstract][Full Text] [Related]
13. Opioids and Chronic Pain: Where Is the Balance?
Davis MP; Mehta Z
Curr Oncol Rep; 2016 Dec; 18(12):71. PubMed ID: 27812860
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
Kurita GP; Ekholm O; Kaasa S; Klepstad P; Skorpen F; Sjøgren P
Brain Behav; 2016 Jul; 6(7):e00471. PubMed ID: 27247849
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.
Kurita GP; Sjøgren P; Ekholm O; Kaasa S; Loge JH; Poviloniene I; Klepstad P
J Clin Oncol; 2011 Apr; 29(10):1297-303. PubMed ID: 21357785
[TBL] [Abstract][Full Text] [Related]
16. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
[TBL] [Abstract][Full Text] [Related]
17. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
Currow DC; Quinn S; Ekstrom M; Kaasa S; Johnson MJ; Somogyi AA; Klepstad P
BMJ Open; 2015 May; 5(5):e006818. PubMed ID: 25948405
[TBL] [Abstract][Full Text] [Related]
18. Impact of genetic polymorphisms on opioid misuse: a scoping review.
Ahmed S; Choudhry Z; Bhatti JA
Pharmacogenomics; 2019 Jun; 20(9):685-703. PubMed ID: 31250732
[TBL] [Abstract][Full Text] [Related]
19. Pain Management for Patients With Advanced Cancer in the Opioid Epidemic Era.
Dalal S; Bruera E
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():24-35. PubMed ID: 31099619
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
